Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Daiichi Sankyo
Accenture
Colorcon
US Army
Boehringer Ingelheim

Generated: August 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,717,750

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,717,750 protect, and when does it expire?

Patent 9,717,750 protects SPINRAZA and is included in one NDA.

This patent has forty-one patent family members in nineteen countries.

Summary for Patent: 9,717,750
Title:Compositions and methods for modulation of SMN2 splicing in a subject
Abstract: Disclosed herein are compounds, compositions and methods for modulating splicing of SMN2 mRNA in a subject. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders, including spinal muscular atrophy.
Inventor(s): Bennett; C. Frank (Carlsbad, CA), Hung; Gene (San Diego, CA), Rigo; Frank (Carlsbad, CA), Krainer; Adrian R. (Huntington Square, NY), Hua; Yimin (Jericho, NY), Passini; Marco A. (Shrewsbury, MA), Shihabuddin; Lamya (Brighton, MA), Cheng; Seng H. (Natick, MA), Klinger; Katherine W. (Sudbury, MA)
Assignee: Biogen MA Inc. (Cambridge, MA) Cold Spring Harbor Laboratory (Cold Spring Harbor, NY)
Application Number:14/617,388
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 9,717,750

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Biogen Idec SPINRAZA nusinersen sodium SOLUTION;INTRATHECAL 209531-001 Dec 23, 2016 RX Yes Yes   Try a Free Trial   Try a Free Trial TREATMENT OF SPINAL MUSCULAR ATROPHY BY INCREASING EXON-7 INCLUSION IN SMN2 MRNA   Try a Free Trial
Biogen Idec SPINRAZA nusinersen sodium SOLUTION;INTRATHECAL 209531-001 Dec 23, 2016 RX Yes Yes   Try a Free Trial   Try a Free Trial TREATMENT OF SPINAL MUSCULAR ATROPHY   Try a Free Trial
Biogen Idec SPINRAZA nusinersen sodium SOLUTION;INTRATHECAL 209531-001 Dec 23, 2016 RX Yes Yes   Try a Free Trial   Try a Free Trial TREATMENT OF TYPE III SPINAL MUSCULAR ATROPHY   Try a Free Trial
Biogen Idec SPINRAZA nusinersen sodium SOLUTION;INTRATHECAL 209531-001 Dec 23, 2016 RX Yes Yes   Try a Free Trial   Try a Free Trial TREATMENT OF TYPE II SPINAL MUSCULAR ATROPHY   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 9,717,750

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2010262862   Try a Free Trial
Australia 2016200344   Try a Free Trial
Canada 2765396   Try a Free Trial
China 102665731   Try a Free Trial
China 106983768   Try a Free Trial
Denmark 3305302   Try a Free Trial
European Patent Office 2408796   Try a Free Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
AstraZeneca
Fish and Richardson
Express Scripts
Citi
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.